Correlation Between Terns Pharmaceuticals and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Design Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Design Therapeutics.
Diversification Opportunities for Terns Pharmaceuticals and Design Therapeutics
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Terns and Design is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Design Therapeutics go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Design Therapeutics
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to under-perform the Design Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Terns Pharmaceuticals is 1.78 times less risky than Design Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Design Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 557.00 in Design Therapeutics on August 31, 2024 and sell it today you would earn a total of 40.00 from holding Design Therapeutics or generate 7.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Design Therapeutics
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Design Therapeutics |
Terns Pharmaceuticals and Design Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Design Therapeutics
The main advantage of trading using opposite Terns Pharmaceuticals and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
| Design Therapeutics vs. Cue Biopharma | Design Therapeutics vs. Eliem Therapeutics | Design Therapeutics vs. Inhibrx | Design Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |